Literature DB >> 3461879

Specific minor chromosome deletions consistently occurring in myelodysplastic syndromes.

B Pedersen, G Kerndrup.   

Abstract

Forty-two patients with refractory anemia with or without sideroblasts have been investigated cytogenetically one to nine times (mean, 3) over a period of 1-36 months (mean, 16). The initial investigation showed numerical and/or major structural abnormalities [t(3;3), 5q-, -7, or 7q-, 11q-] in nine patients (21%). In addition, minimal terminal deletions were observed in 2p, 8p, 9p, 11p, 12p, 17p, 17q, 20q, and Xp. The detection of these deletions, which have not been reported earlier, was due to consistent application of the high resolution technique, G-banding without trypsin, and metaphase photography on large size negatives. Each deletion occurred as a clone on one or more occasions in 1-17 patients (mean, 7). One or other clonal minimal deletion was observed in 32 patients (76%). Preliminary indirect evidence indicates that alone or together with other factors the deletions promote leukemic transformation of refractory anemia.

Entities:  

Mesh:

Year:  1986        PMID: 3461879     DOI: 10.1016/0165-4608(86)90150-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Evolution of multiple cytogenetic clones and leukemic transformation in a case of myelodysplastic syndrome.

Authors:  E Donti; G V Donti; F Falzetti; A Rosetti; F Grignani; A Tabilio
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

2.  Prognostic significance of some clinical, morphological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts.

Authors:  G Kerndrup; B Pedersen; J Ellegaard; P Hokland
Journal:  Blut       Date:  1986-01

3.  The prognostic significance of cytological, histological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts. A follow up study.

Authors:  G Kerndrup; K Bendix-Hansen; B Pedersen
Journal:  Blut       Date:  1987-04

4.  Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C.

Authors:  Lindsey Skrdlant; Jeremy M Stark; Ren-Jang Lin
Journal:  BMC Mol Biol       Date:  2016-08-23       Impact factor: 2.946

5.  Identification of acute myeloid leukemia patients with diminished expression of CD13 myeloid transcripts by competitive reverse transcription polymerase chain reaction (RT-PCR).

Authors:  K Dybkaer; B Pedersen; F Skou Pedersen; J Schøler Kristensen
Journal:  Leuk Res       Date:  2000-06       Impact factor: 3.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.